PEN Penumbra Inc

Penumbra Inc designs, develops, manufactures and markets medical devices. The products of the company address ischemic stroke, hemorrhagic stroke and vascular conditions that can be treated through thrombectomy and embolization procedures.

$284.73  -6.51 (-2.24%)
As of 09/17/2021 16:00:02 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  09/18/2015
Outstanding shares:  36,580,540
Average volume:  164,624
Market cap:   $10,567,386,395
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    70975L107
ISIN:        US70975L1070
Sedol:      BZ0V201
Valuation   (See tab for details)
PE ratio:   670.05
PB ratio:   15.69
PS ratio:   15.74
Return on equity:   2.36%
Net income %:   2.37%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy